Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/13709 |
Resumo: | Faculdade de Ciências Farmacêuticas de Ribeirão Preto. Laboratório de Farmacocinética e Metabolismo. Departamento de Análises Clínicas, Toxicológicas e Bromatológicas. Ribeirão Preto, SP, Brasil |
id |
CRUZ_a308ea54007e898696164599ef034c53 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/13709 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Lanchote, Vera LuciaAlmeida, Roque Pacheco deBarral, Aldina Maria PradoBarral Netto, ManoelMarques, Maria PaulaMoraes, Natália Valadares deSilva, Angela Maraia daSouza, Tania M. VKurtz, Guilherme Suarez2016-04-12T13:12:51Z2016-04-12T13:12:51Z2015LANCHOTE, V. L. et al. Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients. British Journal of Clinical Pharmacology, v. 80, n. 5, p. 1160-1168, 2015.1365-2125https://www.arca.fiocruz.br/handle/icict/1370910.1111/bcp.12677engBritish Pharmacological SocietyLeishmanioseLeishmaniose visceralQuimioterapiaInflamaçãoAdultosCitocromo-P450Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patientsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFaculdade de Ciências Farmacêuticas de Ribeirão Preto. Laboratório de Farmacocinética e Metabolismo. Departamento de Análises Clínicas, Toxicológicas e Bromatológicas. Ribeirão Preto, SP, BrasilUniversidade Federal de Sergipe. Hospital Universitário. Aracaju, SE, BrasilFundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, BrasilFundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, BrasilFaculdade de Ciências Farmacêuticas de Ribeirão Preto. Laboratório de Farmacocinética e Metabolismo. Departamento de Análises Clínicas, Toxicológicas e Bromatológicas. Ribeirão Preto, SP, BrasilFaculdade de Ciências Farmacêuticas de Ribeirão Preto. Laboratório de Farmacocinética e Metabolismo. Departamento de Análises Clínicas, Toxicológicas e Bromatológicas. Ribeirão Preto, SP, BrasilUniversidade Federal de Sergipe. Hospital Universitário. Aracaju, SE, BrasilUniversidade Federal de Sergipe. Hospital Universitário. Aracaju, SE, BrasilInstituto Nacional de Câncer. Divisão de Farmacologia. Rio de Janeiro, RJ, BrasilAIMS: The aim of the present study was to investigate the impact of human visceral leishmaniasis (VL) and curative chemotherapy on the activity of cytochrome P450 (CYP) 3A, CYP2C9 and CYP2C19 in patients from an endemic region in Brazil. METHODS: Adult patients with parasitologically confirmed VL were given a CYP phenotyping cocktail, comprising midazolam, omeprazole and losartan, immediately before (Study phase 1), 2-3 days (phase 2) and 3-6 months (phase 3) after curative VL chemotherapy. CYP activity was assessed by the apparent clearance of midazolam (CYP3A), omeprazole/5-hydroxyomeprazol ratio in plasma (CYP2C19) and losartan/E3174 ratio in urine (CYP2C9). RESULTS: Mean values (95% confidence interval) in phases 1, 2 and 3 were, respectively: log apparent midazolam clearance, 1.21 (1.10-1.31), 1.45 (1.32-1.57) and 1.35 (1.26-1.44) ml min(-1) kg(-1) ; omeprazole/5-hydroxyomeprazole ratio, 0.78 (0.61-0.94), 0.45 (0.27-0.63) and 0.37 (0.20-0.55); losartan/E3174 ratio, 0.66 (0.39-0.92), 0.35 (0.20-0.50) and 0.35 (0.16-0.53). Analysis of variance revealed significant differences in CYP3A (P = 0.018) and CYP2C19 (P = 0.008), but not CYP2C9 (P = 0.11) phenotypic activity, across the three study phases. CONCLUSION: The phenotypic activities of CYP3A4 and CYP2C19 were significantly reduced during acute VL compared with post-chemotherapy. We propose that increased plasma concentrations of proinflammatory cytokines during active disease account for the suppression of CYP activity. The failure to detect significant changes in CYP2C9 activity in the overall cohort may reflect differential effects of the inflammatory process on the expression of CYP isoforms, although the possibility of insufficient statistical power cannot be dismissed.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/13709/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALLanchote, VL. Impact of visceral....pdfLanchote, VL. Impact of visceral....pdfapplication/pdf1105142https://www.arca.fiocruz.br/bitstream/icict/13709/2/Lanchote%2c%20VL.%20Impact%20of%20visceral....pdfbbbaf0c963858cd545018a3daf83495dMD52TEXTLanchote, VL. Impact of visceral....pdf.txtLanchote, VL. Impact of visceral....pdf.txtExtracted texttext/plain38503https://www.arca.fiocruz.br/bitstream/icict/13709/3/Lanchote%2c%20VL.%20Impact%20of%20visceral....pdf.txtc8bee327442aa9689e969008294525e6MD53icict/137092023-03-15 14:34:01.137oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:34:01Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients |
title |
Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients |
spellingShingle |
Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients Lanchote, Vera Lucia Leishmaniose Leishmaniose visceral Quimioterapia Inflamação Adultos Citocromo-P450 |
title_short |
Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients |
title_full |
Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients |
title_fullStr |
Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients |
title_full_unstemmed |
Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients |
title_sort |
Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients |
author |
Lanchote, Vera Lucia |
author_facet |
Lanchote, Vera Lucia Almeida, Roque Pacheco de Barral, Aldina Maria Prado Barral Netto, Manoel Marques, Maria Paula Moraes, Natália Valadares de Silva, Angela Maraia da Souza, Tania M. V Kurtz, Guilherme Suarez |
author_role |
author |
author2 |
Almeida, Roque Pacheco de Barral, Aldina Maria Prado Barral Netto, Manoel Marques, Maria Paula Moraes, Natália Valadares de Silva, Angela Maraia da Souza, Tania M. V Kurtz, Guilherme Suarez |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Lanchote, Vera Lucia Almeida, Roque Pacheco de Barral, Aldina Maria Prado Barral Netto, Manoel Marques, Maria Paula Moraes, Natália Valadares de Silva, Angela Maraia da Souza, Tania M. V Kurtz, Guilherme Suarez |
dc.subject.other.pt_BR.fl_str_mv |
Leishmaniose Leishmaniose visceral Quimioterapia Inflamação Adultos Citocromo-P450 |
topic |
Leishmaniose Leishmaniose visceral Quimioterapia Inflamação Adultos Citocromo-P450 |
description |
Faculdade de Ciências Farmacêuticas de Ribeirão Preto. Laboratório de Farmacocinética e Metabolismo. Departamento de Análises Clínicas, Toxicológicas e Bromatológicas. Ribeirão Preto, SP, Brasil |
publishDate |
2015 |
dc.date.issued.fl_str_mv |
2015 |
dc.date.accessioned.fl_str_mv |
2016-04-12T13:12:51Z |
dc.date.available.fl_str_mv |
2016-04-12T13:12:51Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
LANCHOTE, V. L. et al. Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients. British Journal of Clinical Pharmacology, v. 80, n. 5, p. 1160-1168, 2015. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/13709 |
dc.identifier.issn.none.fl_str_mv |
1365-2125 |
dc.identifier.doi.none.fl_str_mv |
10.1111/bcp.12677 |
identifier_str_mv |
LANCHOTE, V. L. et al. Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients. British Journal of Clinical Pharmacology, v. 80, n. 5, p. 1160-1168, 2015. 1365-2125 10.1111/bcp.12677 |
url |
https://www.arca.fiocruz.br/handle/icict/13709 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
British Pharmacological Society |
publisher.none.fl_str_mv |
British Pharmacological Society |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/13709/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/13709/2/Lanchote%2c%20VL.%20Impact%20of%20visceral....pdf https://www.arca.fiocruz.br/bitstream/icict/13709/3/Lanchote%2c%20VL.%20Impact%20of%20visceral....pdf.txt |
bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 bbbaf0c963858cd545018a3daf83495d c8bee327442aa9689e969008294525e6 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009274961395712 |